Literature DB >> 26143662

Predictors of surgical site infection after hospital discharge in patients undergoing major vascular surgery.

Jason T Wiseman1, Sara Fernandes-Taylor1, Maggie L Barnes1, R Scott Saunders1, Sandeep Saha2, Jeffrey Havlena1, Paul J Rathouz2, K Craig Kent3.   

Abstract

OBJECTIVE: Surgical site infection (SSI) is one of the most common postoperative complications after vascular reconstruction, producing significant morbidity and hospital readmission. In contrast to SSI that develops while patients are still hospitalized, little is known about the cohort of patients who develop SSI after discharge. In this study, we explore the factors that lead to postdischarge SSI, investigate the differences between risk factors for in-hospital vs postdischarge SSI, and develop a scoring system to identify patients who might benefit from postdischarge monitoring of their wounds.
METHODS: Patients who underwent major vascular surgery from 2005 to 2012 for aneurysm and lower extremity occlusive disease were identified from the American College of Surgeons National Surgical Quality Improvement Program Participant Use Files. Patients were categorized as having no SSI, in-hospital SSI, or SSI after hospital discharge. Predictors of postdischarge SSI were determined by multivariable logistic regression and internally validated by bootstrap resampling. Risk scores were assigned to all significant variables in the model. Summative risk scores were collapsed into quartile-based ordinal categories and defined as low, low/moderate, moderate/high, and high risk. Multivariable logistic regression was used to determine predictors of in-hospital SSI.
RESULTS: Of the 49,817 patients who underwent major vascular surgery, 4449 (8.9%) were diagnosed with SSI (2.1% in-hospital SSI; 6.9% postdischarge SSI). By multivariable analysis, factors significantly associated with increased odds of postdischarge SSI include female gender, obesity, diabetes, smoking, hypertension, coronary artery disease, critical limb ischemia, chronic obstructive pulmonary disease, dyspnea, neurologic disease, prolonged operative time >4 hours, American Society of Anesthesiology class 4 or 5, lower extremity revascularization or aortoiliac procedure, and groin anastomosis. The model exhibited moderate discrimination (bias-corrected C statistic, 0.691) and excellent internal calibration. The postdischarge SSI rate was 2.1% for low-risk patients, 5.1% for low/moderate-risk patients, 7.8% for moderate/high-risk patients, and 14% for high-risk patients. In a comparative analysis, comorbidities were the primary driver of postdischarge SSI, whereas in-hospital factors (operative time, emergency case status) and complications predicted in-hospital SSI.
CONCLUSIONS: The majority of SSIs after major vascular surgery develop following hospital discharge. We have created a scoring system that can select a cohort of patients at high risk for SSI after discharge. These patients can be targeted for transitional care efforts focused on early detection and treatment with the goal of reducing morbidity and preventing readmission secondary to SSI.
Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26143662      PMCID: PMC4586313          DOI: 10.1016/j.jvs.2015.04.453

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  31 in total

1.  The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.

Authors:  K B Kirkland; J P Briggs; S L Trivette; W E Wilkinson; D J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  1999-11       Impact factor: 3.254

2.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

Authors:  E W Steyerberg; F E Harrell; G J Borsboom; M J Eijkemans; Y Vergouwe; J D Habbema
Journal:  J Clin Epidemiol       Date:  2001-08       Impact factor: 6.437

3.  Post-discharge surveillance: can patients reliably diagnose surgical wound infections?

Authors:  M Whitby; M-L McLaws; B Collopy; D F L Looke; S Doidge; B Henderson; L Selvey; G Gardner; J Stackelroth; A Sartor
Journal:  J Hosp Infect       Date:  2002-11       Impact factor: 3.926

4.  Readmission after delayed diagnosis of surgical site infection: a focus on prevention using the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  Angela Gibson; Sarah Tevis; Gregory Kennedy
Journal:  Am J Surg       Date:  2013-10-10       Impact factor: 2.565

Review 5.  General and vascular surgery readmissions: a systematic review.

Authors:  Jason T Wiseman; Amanda M Guzman; Sara Fernandes-Taylor; Travis L Engelbert; R Scott Saunders; K Craig Kent
Journal:  J Am Coll Surg       Date:  2014-05-22       Impact factor: 6.113

6.  Epidemiology of surgical-site infections diagnosed after hospital discharge: a prospective cohort study.

Authors:  M Delgado-Rodríguez; A Gómez-Ortega; M Sillero-Arenas; J Llorca
Journal:  Infect Control Hosp Epidemiol       Date:  2001-01       Impact factor: 3.254

7.  Outpatient follow-up versus 30-day readmission among general and vascular surgery patients: a case for redesigning transitional care.

Authors:  Richard Scott Saunders; Sara Fernandes-Taylor; Paul J Rathouz; Sandeep Saha; Jason T Wiseman; Jeffrey Havlena; Jon Matsumura; K Craig Kent
Journal:  Surgery       Date:  2014-10       Impact factor: 3.982

8.  Regional intensity of vascular care and lower extremity amputation rates.

Authors:  Philip P Goodney; Kerianne Holman; Peter K Henke; Lori L Travis; Justin B Dimick; Therese A Stukel; Elliott S Fisher; John D Birkmeyer
Journal:  J Vasc Surg       Date:  2013-02-01       Impact factor: 4.268

9.  Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia.

Authors:  James T McPhee; Louis L Nguyen; Karen J Ho; C Keith Ozaki; Michael S Conte; Michael Belkin
Journal:  J Vasc Surg       Date:  2013-02-06       Impact factor: 4.268

10.  Health and economic impact of surgical site infections diagnosed after hospital discharge.

Authors:  Eli N Perencevich; Kenneth E Sands; Sara E Cosgrove; Edward Guadagnoli; Ellen Meara; Richard Platt
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

View more
  14 in total

1.  Feasibility of an Image-Based Mobile Health Protocol for Postoperative Wound Monitoring.

Authors:  Rebecca L Gunter; Sara Fernandes-Taylor; Shahrose Rahman; Lola Awoyinka; Kyla M Bennett; Sharon M Weber; Caprice C Greenberg; K Craig Kent
Journal:  J Am Coll Surg       Date:  2018-01-19       Impact factor: 6.113

2.  Discharge to a Post-Acute Care Facility after Emergent Femoral Artery Repair is Not Protective Against Wound Complications.

Authors:  Joseph Anderson; Ryan King; Thomas Brothers; Jacob Robison; Ravi Veeraswamy; Mathew Wooster; Rupak Mukherjee; Jean Marie Ruddy
Journal:  Ann Vasc Surg       Date:  2020-01-07       Impact factor: 1.466

3.  Risk Factors for 30-Day Hospital Re-Admission with an Infectious Complication after Lower-Extremity Vascular Procedures.

Authors:  Joseph C Melvin; Jamie B Smith; Robin L Kruse; Todd R Vogel
Journal:  Surg Infect (Larchmt)       Date:  2017-02-08       Impact factor: 2.150

4.  Ultrasound-Guided Thrombin Injection Is a Safe and Effective Treatment for Femoral Artery Pseudoaneurysm in the Morbidly Obese.

Authors:  Taehwan Yoo; Jean E Starr; Michael R Go; Patrick S Vaccaro; Bhagwan Satiani; Mounir J Haurani
Journal:  Vasc Endovascular Surg       Date:  2017-05-31       Impact factor: 1.089

5.  Inter-rater agreement and checklist validation for postoperative wound assessment using smartphone images in vascular surgery.

Authors:  Jason T Wiseman; Sara Fernandes-Taylor; Rebecca Gunter; Maggie L Barnes; Richard Scott Saunders; Paul J Rathouz; Dai Yamanouchi; K Craig Kent
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2016-03-26

6.  Groin wound infection after vascular exposure (GIVE) multicentre cohort study.

Authors: 
Journal:  Int Wound J       Date:  2020-11-25       Impact factor: 3.315

Review 7.  Regulated Cell Death as a Therapeutic Target for Novel Antifungal Peptides and Biologics.

Authors:  Michael R Yeaman; Sabrina Büttner; Karin Thevissen
Journal:  Oxid Med Cell Longev       Date:  2018-04-26       Impact factor: 6.543

8.  Telemedicine platforms and their use in the coronavirus disease-19 era to deliver comprehensive vascular care.

Authors:  Judith C Lin; Misty D Humphries; William P Shutze; Oliver O Aalami; Uwe M Fischer; Kim J Hodgson
Journal:  J Vasc Surg       Date:  2020-07-02       Impact factor: 4.268

Review 9.  Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States.

Authors:  Keith S Kaye; Lindsay A Petty; Andrew F Shorr; Marya D Zilberberg
Journal:  Clin Infect Dis       Date:  2019-04-08       Impact factor: 9.079

10.  Evaluating Patient Usability of an Image-Based Mobile Health Platform for Postoperative Wound Monitoring.

Authors:  Rebecca Gunter; Sara Fernandes-Taylor; Andrea Mahnke; Lola Awoyinka; Chad Schroeder; Jason Wiseman; Sarah Sullivan; Kyla Bennett; Caprice Greenberg; K Craig Kent
Journal:  JMIR Mhealth Uhealth       Date:  2016-09-28       Impact factor: 4.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.